Institutional Fund
Soleus Capital Management, L.P.
Greenwich, CTCIK 18026305 filings on record
Portfolio Value
$2.47B
Q1 2026
Holdings
93
Reported positions
New Buys
25
Opened this quarter
QoQ Change
+4.7%
from $2.36B
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Krystal Biotech Inc12.1%
- Celcuity Inc5.9%
- Tg Therapeutics Inc5.4%
- Insulet Corp4.8%
- Novocure Ltd4.6%
- United Therapeutics Corp Del4.5%
- Other62.7%
Portfolio Holdings
93 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Krystal Biotech Inc | 1.15M | $297.87M | 12.1% | +212.0K | Added |
| 2 | Celcuity Inc | 1.28M | $146.60M | 5.9% | −523.9K | Reduced |
| 3 | Tg Therapeutics Inc | 4.03M | $133.85M | 5.4% | +890.0K | Added |
| 4 | Insulet Corp | 562.5K | $118.03M | 4.8% | +412.5K | Added |
| 5 | Novocure Ltd | 10.49M | $114.37M | 4.6% | +1.96M | Added |
| 6 | United Therapeutics Corp Del | 187.2K | $111.00M | 4.5% | +127.2K | Added |
| 7 | Praxis Precision Medicines I | 330.5K | $106.49M | 4.3% | −32.4K | Reduced |
| 8 | Vericel Corp | 2.55M | $82.00M | 3.3% | +1.79M | Added |
| 9 | Alkermes PLC | 1.97M | $69.69M | 2.8% | +648.5K | Added |
| 10 | Ani Pharmaceuticals Inc | 820.2K | $63.08M | 2.6% | +334.0K | Added |
83 more holdings on Premium
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio